Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Torres-Trejo

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Neuro-Oncology Practice|April 4, 2022
Patients with brain metastasis and the risk of falls: a plausibly preventable entityAlejandro Torres-Trejo, David M Peereboom
The West Virginia Medical Journal|February 17, 2011
Altitude induced migraineDavid B Watson, Alejandro Torres-Trejo, Ludwig Gutmann
The Neurohospitalist|June 19, 2024
Diagnostic Challenges of Lyme Neuroborreliosis in Inpatient Neurology: A Case SeriesKaitlyn N Palmer, Maria Sokola, Sanem P Uysal, et al.
Frontiers in Oncology|March 13, 2023
The role of targeted therapy and immune therapy in the management of non-small cell lung cancer brain metastasesCole Billena, Mina Lobbous, Christine A Cordova, et al.
Neuro-Oncology Advances|December 31, 2025
Intracerebral hemorrhage risk in glioma patients taking direct oral anticoagulants as compared with low molecular weight heparinRadhika S Amin, Scott Cameron, Matthew M Grabowski, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 1, 2026
TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 GliomasMomina Qureshi, David Peereboom, Emily Zabor, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 GliomasMomina Qureshi, David Peereboom, Emily Zabor, et al.
Journal of Translational Medicine|December 21, 2007
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomasHideho Okada, Frank S Lieberman, Kevin A Walter, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastomaPhioanh Leia Nghiemphu, Patrick Y Wen, Kathleen R Lamborn, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Neuro-Oncology Practice|April 4, 2022
Patients with brain metastasis and the risk of falls: a plausibly preventable entityAlejandro Torres-Trejo, David M Peereboom
The West Virginia Medical Journal|February 17, 2011
Altitude induced migraineDavid B Watson, Alejandro Torres-Trejo, Ludwig Gutmann
The Neurohospitalist|June 19, 2024
Diagnostic Challenges of Lyme Neuroborreliosis in Inpatient Neurology: A Case SeriesKaitlyn N Palmer, Maria Sokola, Sanem P Uysal, et al.
Frontiers in Oncology|March 13, 2023
The role of targeted therapy and immune therapy in the management of non-small cell lung cancer brain metastasesCole Billena, Mina Lobbous, Christine A Cordova, et al.
Neuro-Oncology Advances|December 31, 2025
Intracerebral hemorrhage risk in glioma patients taking direct oral anticoagulants as compared with low molecular weight heparinRadhika S Amin, Scott Cameron, Matthew M Grabowski, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 1, 2026
TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 GliomasMomina Qureshi, David Peereboom, Emily Zabor, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 GliomasMomina Qureshi, David Peereboom, Emily Zabor, et al.
Journal of Translational Medicine|December 21, 2007
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomasHideho Okada, Frank S Lieberman, Kevin A Walter, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastomaPhioanh Leia Nghiemphu, Patrick Y Wen, Kathleen R Lamborn, et al.
Pageof 1